Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 52,674 | 50,394 | 50,027 | 47,620 | 46,407 |
| Cost of Goods | 24,207 | 23,732 | 21,980 | 21,346 | 20,836 |
| Gross Profit | 28,467 | 26,662 | 28,047 | 26,274 | 25,571 |
| Operating Expenses | 28,499 | 27,201 | 27,020 | 25,296 | 25,561 |
| Operating Income | 175 | 193 | 2,007 | 1,324 | 846 |
| Interest Expense | 11 | 37 | 50 | 89 | 100 |
| Other Income | -19 | 22 | 118 | 342 | 219 |
| Pre-tax Income | 145 | 178 | 2,075 | 1,577 | 965 |
| Income Tax | 548 | 445 | 343 | 22 | 415 |
| Net Income Continuous | -403 | -267 | 1,732 | 1,555 | 550 |
| Net Income | $-403 | $-267 | $1,732 | $1,555 | $550 |
| EPS Basic Total Ops | -0.01 | -0.01 | 0.05 | 0.04 | 0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | 0.05 | 0.04 | 0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | 0.04 | 0.04 | 0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | 0.04 | 0.04 | 0.01 |
| EBITDA(a) | $2,744 | $2,909 | $4,947 | $4,021 | $3,516 |